Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
Cutera, Inc. stock logo
CUTR
Cutera
$0.04
-63.9%
$0.13
$0.09
$3.00
$787K1.362.32 million shs27.70 million shs
NIMU
Non-Invasive Monitoring Systems
$0.00
+20.0%
$0.00
$0.00
$0.02
$743K0.6326,213 shs46,800 shs
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
$0.00
$0.00
$0.00
$213K0.16218,336 shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
Cutera, Inc. stock logo
CUTR
Cutera
0.00%0.00%0.00%-91.61%-98.01%
NIMU
Non-Invasive Monitoring Systems
+20.00%+20.00%+45.45%+108.70%-60.00%
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
1.2219 of 5 stars
3.30.00.00.00.01.70.6
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARDMQ
Aradigm
0.00
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$3.007,592.31% Upside
NIMU
Non-Invasive Monitoring Systems
0.00
N/AN/AN/A
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
$155.21M0.01N/AN/A($8.62) per share0.00
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/A
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARDMQ
Aradigm
N/AN/A0.00N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
-$162.83M-$6.58N/AN/AN/A-84.86%N/A-45.07%5/7/2025 (Estimated)
NIMU
Non-Invasive Monitoring Systems
-$110KN/A0.00N/AN/AN/A-161.26%N/A
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARDMQ
Aradigm
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/A
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARDMQ
Aradigm
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/A
2.88
1.86
NIMU
Non-Invasive Monitoring Systems
N/A
0.05
0.05
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ARDMQ
Aradigm
N/A
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
NIMU
Non-Invasive Monitoring Systems
0.12%
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/A

Insider Ownership

CompanyInsider Ownership
ARDMQ
Aradigm
4.50%
Cutera, Inc. stock logo
CUTR
Cutera
0.42%
NIMU
Non-Invasive Monitoring Systems
28.80%
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ARDMQ
Aradigm
2315.28 millionN/ANot Optionable
Cutera, Inc. stock logo
CUTR
Cutera
46020.19 million20.10 millionOptionable
NIMU
Non-Invasive Monitoring Systems
3154.81 millionN/ANot Optionable
Todos Medical Ltd. stock logo
TOMDF
Todos Medical
72.13 billionN/ANot Optionable

Recent News About These Companies

Todos os Golos do Dia na UEFA Champions League
Vamos Todos Morrer
Todos Medical Ltd TOMDF
Todos Medical Announces Insolvency Proceedings in Israel
TOMDF Historical Data
Todos Medical Ltd. (TOMDF)
Todos Medical Supports Long COVID Awareness Day

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aradigm OTCMKTS:ARDMQ

$0.05 0.00 (0.00%)
As of 06/30/2020

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Cutera stock logo

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Non-Invasive Monitoring Systems OTCMKTS:NIMU

$0.0048 +0.00 (+20.00%)
As of 04/24/2025 03:44 PM Eastern

Non-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.

Todos Medical stock logo

Todos Medical OTCMKTS:TOMDF

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.